David A Morrow Selected Research

Stents

1/2020	Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.
11/2018	Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
3/2016	Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
12/2014	Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial.
1/2012	American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38).
5/2006	Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Morrow Research Topics

Disease

146	Myocardial Infarction 02/2024 - 06/2002
135	Acute Coronary Syndrome 01/2023 - 02/2002
81	Heart Failure 03/2024 - 05/2004
57	ST Elevation Myocardial Infarction 01/2022 - 07/2002
45	Hemorrhage 01/2024 - 04/2005
44	Stroke (Strokes) 01/2024 - 08/2006
43	Ischemia 01/2022 - 04/2003
27	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2002
27	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2002
26	Atherosclerosis 08/2022 - 02/2003
25	Thrombosis (Thrombus) 01/2023 - 07/2002
19	Cardiogenic Shock 04/2024 - 09/2010
18	Inflammation (Inflammations) 07/2023 - 02/2003
18	Peripheral Arterial Disease 10/2021 - 09/2009
17	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
17	Unstable Angina 02/2017 - 06/2002
16	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 07/2002
15	Type 2 Diabetes Mellitus (MODY) 10/2023 - 10/2014
15	Hypertension (High Blood Pressure) 01/2023 - 02/2003
14	Shock 01/2024 - 01/2019
14	COVID-19 03/2023 - 01/2020
13	Atrial Fibrillation 01/2024 - 01/2015
13	Ischemic Stroke 01/2023 - 09/2009
13	Diabetes Mellitus 11/2021 - 04/2006
11	Infarction (Infarctions) 01/2022 - 07/2002
10	Infections 01/2020 - 10/2005
9	Heart Arrest (Cardiac Arrest) 11/2023 - 01/2019
8	Necrosis 01/2016 - 01/2003
7	Chronic Renal Insufficiency 01/2023 - 04/2006
7	Critical Illness (Critically Ill) 01/2023 - 01/2019
7	Respiratory Insufficiency (Respiratory Failure) 08/2022 - 01/2018
7	Coronary Disease (Coronary Heart Disease) 09/2016 - 02/2003
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2014 - 10/2005
6	Chest Pain (Chest Pains) 10/2023 - 09/2013
6	Transient Ischemic Attack 01/2019 - 12/2014
5	Vascular Diseases (Vascular Disease) 01/2023 - 08/2003
5	Heart Diseases (Heart Disease) 08/2022 - 12/2010
5	Ventricular Tachycardia 01/2021 - 08/2010
4	Hypotension (Low Blood Pressure) 03/2024 - 01/2019
4	Cardiac Arrhythmias (Arrythmia) 03/2024 - 04/2007
4	Pathologic Constriction (Stenosis) 03/2024 - 08/2004
4	Embolism (Embolus) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

79	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
39	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 02/2002
35	TroponinIBA 10/2023 - 07/2002
31	C-Reactive ProteinIBA 01/2022 - 04/2002
26	vorapaxarIBA 08/2022 - 09/2009
24	Ranolazine FDA Link 01/2021 - 06/2006
23	Neurofibromin 2 (Merlin)IBA 01/2021 - 06/2006
22	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 11/2005
22	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 06/2002
21	Troponin IIBA 01/2021 - 04/2002
18	Natriuretic PeptidesIBA 12/2023 - 01/2003
17	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 02/2005
16	Troponin T (Troponin T1)IBA 12/2022 - 07/2002
14	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 01/2018
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 10/2005
14	Clopidogrel (Plavix)FDA Link 11/2022 - 12/2005
13	AnticoagulantsIBA 01/2024 - 03/2005
12	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
11	Enalapril FDA LinkGeneric 03/2024 - 01/2018
11	omega-Chloroacetophenone (Mace)IBA 01/2023 - 06/2007
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2005
11	Atorvastatin (Lipitor)FDA Link 06/2011 - 05/2005
11	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 05/2005
10	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
10	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2002
9	CreatinineIBA 01/2024 - 11/2003
8	dapagliflozinIBA 10/2023 - 01/2021
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
7	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 06/2015
7	Growth Differentiation Factor 15IBA 01/2023 - 10/2010
7	Thrombin FDA Link 10/2019 - 04/2005
7	AntithrombinsIBA 09/2010 - 08/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 06/2006
5	trans-crotonin (CTN)IBA 10/2023 - 11/2013
5	CytokinesIBA 07/2023 - 02/2006
5	Valsartan (Vals)FDA Link 01/2023 - 08/2010
5	Thromboplastin (Tissue Factor)IBA 01/2023 - 04/2005
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2022 - 09/2009
5	oxidized low density lipoproteinIBA 01/2022 - 05/2005
5	saxagliptin FDA Link 11/2021 - 10/2014
5	TicagrelorIBA 11/2020 - 09/2016
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
5	alogliptinIBA 01/2018 - 01/2017
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 04/2006
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014 - 11/2005
5	N(2)-(3-trifluoromethylphenyl)guanineIBA 11/2011 - 07/2002
5	CalciumIBA 10/2007 - 11/2005
4	Vitamin K FDA Link 01/2024 - 06/2015
4	Hemoglobins (Hemoglobin)IBA 10/2023 - 04/2005

Therapy/Procedure

89	Therapeutics 10/2023 - 07/2002
25	Percutaneous Coronary Intervention 01/2022 - 11/2003
21	Critical Care (Surgical Intensive Care) 04/2024 - 01/2015
19	Secondary Prevention 10/2021 - 09/2009
11	Thrombolytic Therapy 09/2010 - 11/2004
6	Extracorporeal Membrane Oxygenation 11/2023 - 01/2018
6	Patient Readmission 01/2021 - 02/2004
6	Stents 01/2020 - 05/2006
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 09/2008